Our OIC Drug

Discussion in 'Shionogi' started by Anonymous, Oct 13, 2014 at 4:44 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Wasn't this supposed to be our product? I remember hearing about a deal with Nektar about two years ago at the POA in Texas. Did we miss the boat?



    Nektar says FDA clears constipation drug Movantik
    Nektar says FDA approves Movantik, a treatment for constipation caused by pain drugs
    Associated Press
    1 hour ago

    NEW YORK (AP) -- Nektar Therapeutics said Tuesday that U.S. regulators approved its drug Movantik, a once-per-day treatment for constipation caused by opioid painkillers.

    Movantik, or naloxegol, is approved for adults who have chronic pain that is not caused by cancer. British drugmaker AstraZeneca PLC will market the drug, and it has also filed for regulatory approval in the European Union and Canada.

    Constipation is a common side effect of the painkillers, which include morphine, Oxycontin and Vicodin.

    The San Francisco company said Movantik will be available to patients in the first half of 2015. AstraZeneca will conduct a study to evaluate the drug's cardiovascular side effects.

    Shares of Nektar Therapeutics rose 34 cents, or 2.5 percent, to $13.87 in afternoon trading. AstraZeneca stock fell 9 cents to $73.6
     

  2. Anonymous

    Anonymous Guest

    Be better. Go disrupt now.